Once you’ve decided to bring a neuroproduct to market, adding the R&D and technical management members of your team is expensive in not just money but millions in upside from giving away too much equity.

Don’t give up essential equity and resources you need to launch big.

Focus your resources and equity on the clinical aspects, leaving the neurotech-based R&D, prototyping, testing and manufacturing to our experienced team.